Trial intelligence / Profile preview

Effects of caffeine dose on bowel function recovery following gynecologic cancer surgery

TCTR20221001002Phase 4Completed

Sponsor
N/A
Start
Jan 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of caffeine in gynecological cancer, sponsored by N/A. Started Jan 2022; status: completed.

02

Drugs

caffeine
03

Conditions

gynecological cancer

Beyond the preview

Go deeper on TCTR20221001002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20221001002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call